MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Revenue
$110,715K
Net Income
-$44,089K
Net Profit Margin
-39.82%
EPS
-$0.71
Unit: Thousand (K) dollars
Revenue Breakdown
    • Americas
    • EMEA
    • Asia Pacific
Revenue Breakdown
    • Ngs Tools
    • Antibody Discovery
Revenue Breakdown
    • Industrial Chemicals
    • Diagnostics
    • Academic Research
    • Others
Revenue Breakdown
    • Selling, general and administrat...
    • Cost of revenues
    • Stock-based compensation expense
    • Others

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Revenues
110,715 103,698 99,009 96,057
Cost of revenues
53,593 49,726 48,172 44,760
Research and development expenses
19,695 17,130 17,014 18,047
Selling, general and administrative expenses
76,085 69,742 63,758 63,370
Restructuring and other costs
NaN NaN 0* NaN
Change in fair value of contingent considerations and holdbacks
NaN NaN 0* NaN
Impairment of long-lived assets
NaN NaN 0* 0
Litigation settlement costs, net of recoveries
7,205 NaN NaN NaN
Total costs and expenses
156,578 136,598 128,944 126,177
Loss from operations
-45,863 -32,900 -29,935 -30,120
Loss on sale of business
NaN NaN 167 48,847
Interest income
1,710 2,175 2,633 2,690
Other income (expense), net
175 471 253 -836
Loss before income taxes
-43,978 -30,254 -26,882 20,581
Income tax expense
43 253 253 191
Net loss
-44,021 -30,507 -27,138 20,390
Change in unrealized loss (gain) on investments
-85 18 11 -25
Foreign currency translation adjustment
17 38 208 -177
Comprehensive loss
-44,089 -30,451 -26,919 20,188
Basic EPS
-0.71 -0.5 -0.445 0.34
Diluted EPS
-0.71 -0.5 -0.454 0.33
Basic Average Shares
61,702,000 61,080,000 60,426,000 59,995,000
Diluted Average Shares
61,702,000 61,080,000 59,257,000 61,164,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Comprehensive loss-$44,089K (-12.12%↓ Y/Y)Foreign currencytranslation adjustment$17K (168.00%↑ Y/Y)Net loss-$44,021K (-11.93%↓ Y/Y)Change in unrealizedloss (gain) on...-$85K (-383.33%↓ Y/Y)Loss before incometaxes-$43,978K (-12.32%↓ Y/Y)Income tax expense$43K (-75.43%↓ Y/Y)Interest income$1,710K (-38.95%↓ Y/Y)Other income(expense), net$175K (169.72%↑ Y/Y)Americas$64,307K (16.52%↑ Y/Y)EMEA$37,347K (21.88%↑ Y/Y)Asia Pacific$9,061K (30.15%↑ Y/Y)Loss from operations-$45,863K (-10.35%↓ Y/Y)Revenues$110,715K (19.31%↑ Y/Y)Total costs andexpenses$156,578K (16.54%↑ Y/Y)Selling, general andadministrative expenses$76,085K (19.50%↑ Y/Y)Cost of revenues$53,593K (14.60%↑ Y/Y)Research and developmentexpenses$19,695K (-17.65%↓ Y/Y)Litigation settlementcosts, net of...$7,205K

Twist Bioscience Corp (TWST)

Twist Bioscience Corp (TWST)